Abstract
We infer the infection fatality ratio (IFR) of SARS-CoV-2 in Brazil by combining three datasets. We compute the prevalence via the population-based seroprevalence survey EPICOVID19-BR. For the fatalities we obtain the absolute number using the public Painel Coronavírus dataset and the age-relative number using the public SIVEP-Gripe dataset. The time delay between the development of antibodies and subsequent fatality is estimated via the SIVEP-Gripe dataset. We obtain the IFR via Bayesian inference for each survey stage and 27 federal states. We include the effect of fading IgG antibody levels by marginalizing over the time after contagion at which the test gives a negative result with a flat prior on the interval [40, 80] days. We infer a country-wide average IFR (maximum posterior and 95% CI) of 0.97% (0.82–1.14%) and age-specific IFR: 0.028% (0.024–0.036%) [< 30 years], 0.21% (0.17–0.25%) [30–49 years], 1.06% (0.88–1.31%) [50–69 years], 2.9% (2.5–3.7%) [≥ 70 years].
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was provided.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
v2: updated to include the effect of fading IgG levels. v3: updated to include the IFR for various age bins.
Data Availability
The data and codes used for this work are made publicly available.
